Amvis Holdings, Inc.

TSE:7071 Stock Report

Market Cap: JP¥92.4b

Amvis Holdings Valuation

Is 7071 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 7071 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 7071 (¥944) is trading above our estimate of fair value (¥832.43)

Significantly Below Fair Value: 7071 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 7071?

Key metric: As 7071 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 7071. This is calculated by dividing 7071's market cap by their current earnings.
What is 7071's PE Ratio?
PE Ratio12.4x
EarningsJP¥7.44b
Market CapJP¥92.38b

Price to Earnings Ratio vs Peers

How does 7071's PE Ratio compare to its peers?

The above table shows the PE ratio for 7071 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average14.1x
9229 SunwelsLtd
14x33.2%JP¥30.3b
7061 Japan Hospice Holdings
20.2x35.6%JP¥11.8b
2374 Saint-Care Holding
10.4x14.4%JP¥18.0b
6039 Japan Animal Referral Medical Center
11.8x15.8%JP¥5.6b
7071 Amvis Holdings
12.4x8.2%JP¥92.4b

Price-To-Earnings vs Peers: 7071 is good value based on its Price-To-Earnings Ratio (12.4x) compared to the peer average (14.1x).

Price to Earnings Ratio vs Industry

How does 7071's PE Ratio compare vs other companies in the JP Healthcare Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
7071 12.4xIndustry Avg. 14.2xNo. of Companies9PE0816243240+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 7071 is good value based on its Price-To-Earnings Ratio (12.4x) compared to the JP Healthcare industry average (14.2x).

Price to Earnings Ratio vs Fair Ratio

What is 7071's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

7071 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio12.4x
Fair PE Ratio21.6x

Price-To-Earnings vs Fair Ratio: 7071 is good value based on its Price-To-Earnings Ratio (12.4x) compared to the estimated Fair Price-To-Earnings Ratio (21.6x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 7071 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentJP¥944.00
JP¥1,702.50
+80.3%
36.6%JP¥2,700.00JP¥1,100.00n/a4
Nov ’25JP¥1,957.00
JP¥2,892.50
+47.8%
17.1%JP¥3,730.00JP¥2,440.00n/a4
Oct ’25JP¥1,955.00
JP¥2,967.50
+51.8%
16.3%JP¥3,730.00JP¥2,440.00n/a4
Sep ’25JP¥2,480.00
JP¥3,067.50
+23.7%
12.9%JP¥3,730.00JP¥2,740.00n/a4
Aug ’25JP¥2,564.00
JP¥3,095.00
+20.7%
11.1%JP¥3,680.00JP¥2,800.00n/a4
Jul ’25JP¥2,221.00
JP¥3,095.00
+39.4%
11.1%JP¥3,680.00JP¥2,800.00n/a4
Jun ’25JP¥1,978.00
JP¥3,145.00
+59.0%
9.9%JP¥3,680.00JP¥2,900.00n/a4
May ’25JP¥2,171.00
JP¥3,215.00
+48.1%
13.4%JP¥3,960.00JP¥2,900.00n/a4
Apr ’25JP¥2,514.00
JP¥3,315.00
+31.9%
11.8%JP¥3,960.00JP¥3,000.00n/a4
Mar ’25JP¥2,470.00
JP¥3,290.00
+33.2%
12.6%JP¥3,960.00JP¥2,900.00n/a4
Feb ’25JP¥2,680.00
JP¥3,677.50
+37.2%
14.7%JP¥4,430.00JP¥2,900.00n/a4
Jan ’25JP¥3,005.00
JP¥3,677.50
+22.4%
14.7%JP¥4,430.00JP¥2,900.00n/a4
Dec ’24JP¥2,811.00
JP¥3,677.50
+30.8%
14.7%JP¥4,430.00JP¥2,900.00n/a4
Nov ’24JP¥2,471.00
JP¥3,582.50
+45.0%
13.4%JP¥4,250.00JP¥2,900.00JP¥1,957.004
Oct ’24JP¥2,603.00
JP¥3,982.50
+53.0%
5.1%JP¥4,250.00JP¥3,680.00JP¥1,955.004
Sep ’24JP¥2,953.00
JP¥3,982.50
+34.9%
5.1%JP¥4,250.00JP¥3,680.00JP¥2,480.004
Aug ’24JP¥2,801.00
JP¥3,980.00
+42.1%
5.0%JP¥4,240.00JP¥3,680.00JP¥2,564.004
Jul ’24JP¥3,265.00
JP¥4,055.00
+24.2%
6.0%JP¥4,300.00JP¥3,680.00JP¥2,221.004
Jun ’24JP¥3,025.00
JP¥3,935.00
+30.1%
11.2%JP¥4,300.00JP¥3,200.00JP¥1,978.004
May ’24JP¥2,858.00
JP¥3,980.00
+39.3%
11.9%JP¥4,400.00JP¥3,200.00JP¥2,171.004
Apr ’24JP¥3,070.00
JP¥3,980.00
+29.6%
11.9%JP¥4,400.00JP¥3,200.00JP¥2,514.004
Mar ’24JP¥3,090.00
JP¥3,980.00
+28.8%
11.9%JP¥4,400.00JP¥3,200.00JP¥2,470.004
Feb ’24JP¥3,460.00
JP¥3,522.50
+1.8%
8.1%JP¥3,900.00JP¥3,200.00JP¥2,680.004
Jan ’24JP¥3,340.00
JP¥3,522.50
+5.5%
8.1%JP¥3,900.00JP¥3,200.00JP¥3,005.004
Dec ’23JP¥3,355.00
JP¥3,522.50
+5.0%
8.1%JP¥3,900.00JP¥3,200.00JP¥2,811.004
Nov ’23JP¥2,924.00
JP¥3,187.50
+9.0%
4.5%JP¥3,400.00JP¥3,000.00JP¥2,471.004

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

FINDEX

JP¥20.8b

Offers medical systems, office systems, and Healthtech products in Japan.

3649

JP¥800.00

7D

-0.7%

1Y

-12.5%

Suzuken

JP¥377.2b

Primarily engages in the distribution of pharmaceuticals in Japan and internationally.

9987

JP¥4,946.00

7D

-2.6%

1Y

-1.6%

TOKAI

JP¥75.1b

Provides various healthy life services in Japan.

9729

JP¥2,214.00

7D

0.05%

1Y

16.4%